Korro Bio CEO disposes shares for tax withholding
Korro Bio, Inc. director and President & CEO Ram Aiyar reported a disposition of common stock primarily tied to equity compensation.
Rhea-AI Filing Summary
Korro Bio, Inc. director and President & CEO Ram Aiyar reported a disposition of common stock primarily tied to equity compensation. On the reported date, 15,152 shares of common stock were sold at a weighted-average price of $12.98 per share solely to satisfy tax withholding obligations arising from the vesting and settlement of a performance stock unit award. Following this tax-related sale, Aiyar directly held 74,848 shares of common stock, and an additional 4,613 shares were held indirectly through The Ram Aiyar Irrevocable Trust, for which he serves as trustee and disclaims beneficial ownership except for any pecuniary interest. The filing also notes that his holdings include 40,000 shares of common stock issuable upon settlement of a restricted stock unit granted under the company’s 2023 equity plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 15,152 | $12.98 | $197K |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. Represents the sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a performance stock unit.
- F2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $12.62 to $13.245, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
- F3. Includes 40,000 shares of common stock issuable upon settlement of a restricted stock unit granted under the 2023 Plan as reported on Form 4 dated February 3, 2026.
- F4. Shares held by The Ram Aiyar Irrevocable Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Key Terms
performance stock unit financial
restricted stock unit financial
irrevocable trust financial
weighted-average price financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Korro Bio (KRRO) report for Ram Aiyar?
Was the Korro Bio (KRRO) insider sale a discretionary trade or for taxes?
What is the role of The Ram Aiyar Irrevocable Trust in Korro Bio (KRRO) holdings?
What equity awards are referenced in Ram Aiyar’s Korro Bio (KRRO) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.